The delay follows leadership changes within the FDA. Dr. Scott Steele has been appointed acting director of the agency’s ...
The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on ...
The FDA was scheduled to release its decision on Novavax’s updated, protein-based COVID-19 vaccine on April 1.
The U.S. Food and Drug Administration has missed its deadline for making a decision on traditional approval for Novavax's ...
Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...
The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.
Novavax started the week hoping the FDA would issue a full approval of its Covid vaccine. But the decision never came.
The FDA was supposed to make a final decision about approval of Novavax's COVID-19 vaccine this week, but that deadline has ...
The delay dovetails with moves by Republican lawmakers in at least seven states to ban or limit mRNA vaccines. Some, according to KFF Health News, are also pressing regulators to revoke federal ...
The delayed decision comes amid a major organizational shakeup that included the departure of top vaccine official Peter ...
“As of Tuesday, April 1, we had responded to all of the FDA’s information requests and we believe that our [Biologics License Application] is ready for approval,” Novavax said in a ...
The U.S. Food and Drug Administration has missed its deadline for making a decision on traditional approval for Novavax's ...